Revenue
-
Net Income
-$446.2M
▼ 40.6% YoY
EPS
$-3.47
▼ 3.0% YoY
Cash
$893.4M
▲ 105.2% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Posner Brian S Insider | Buy | Jun 8, 2026 | 2.0K | $16.94 | $34K | Form 4 ↗ |
Posner Brian S Insider | Buy | Jun 3, 2026 | 2.5K | $17.48 | $44K | Form 4 ↗ |
Posner Brian S Insider | Buy | May 26, 2026 | 2.0K | $18.21 | $36K | Form 4 ↗ |
Posner Brian S Insider | Buy | May 20, 2026 | 2.5K | $17.12 | $43K | Form 4 ↗ |
Friedl-Naderer Johanna Chief Commercial Officer | Sell | May 13, 2026 | 228 | $18.36 | $4K | Form 4 ↗ |
Kerr Douglas Chief Medical Officer | Sell | May 13, 2026 | 1.6K | $18.36 | $29K | Form 4 ↗ |